Results 1 to 10 of about 18,685 (89)

Heart Failure With Mid-range Ejection Fraction. [PDF]

Curr Heart Fail Rep, 2020
To describe the epidemiology, pathophysiology, management, and prognosis of patients with heart failure with mid-range ejection fraction (HFmrEF).In 2013, The American Heart Association (AHA)/American College of Cardiology (ACC) assigned an ejection fraction (EF) range to heart failure with reduced ejection fraction (HFrEF, EF ≤ 40%) and heart failure ...
Srivastava PK, Hsu JJ, Ziaeian B, Fonarow GC.   +3 more
europepmc   +7 more sources

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction. [PDF]

Front Cardiovasc Med, 2021
Pulmonary hypertension (PH) is common in patients with heart failure (HF). The role of PH in patients with HF with reduced (HFrEF) and preserved (HFpEF) left ventricular ejection fraction (LVEF) has been extensively characterized during the last years. In contrast, the pathophysiology of HF with mid-range LVEF (HFmrEF), and in particular the role of PH
Maeder MT, Weber L, Buser M, Brenner R, Joerg L, Rickli H.   +5 more
europepmc   +5 more sources

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides. [PDF]

Front Cardiovasc Med, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities, we summarize potentially beneficial therapies that can delay the process of heart failure by ...
Zhu K, Ma T, Su Y, Pan X, Huang R, Zhang F, Yan C, Xu D.   +7 more
europepmc   +5 more sources

Mortality from Heart Failure with Mid-Range Ejection Fraction. [PDF]

Arq Bras Cardiol, 2022
The prognostic importance of the classification 'heart failure (HF) with mid-range ejection fraction (EF)' remains uncertain.To analyze the clinical characteristics, comorbidities, complications, and in-hospital and late mortality of patients classified as having HF with mid-range EF (HFmrEF - EF: 40%-49%), and to compare them to those of patients with
Dutra GP, Gomes BFO, Carmo Júnior PRD, Petriz JLF, Nascimento EM, Pereira BB, Oliveira GMM.   +6 more
europepmc   +3 more sources

Predictors and outcomes of heart failure with mid-range ejection fraction. [PDF]

Eur J Heart Fail, 2018
Aims While heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF) are well described, determinants and outcomes of heart failure with mid‐range ejection fraction (HFmrEF) remain unclear. We sought to examine clinical and biochemical predictors of incident HFmrEF in the community.
Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, de Filippi CR, Enserro D, Blaha MJ, Cushman M, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Lee DS, Brouwers FP, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL, Levy D, Herrington DM, van Gilst WH, Bertoni AG, Larson MG, de Boer RA, Gottdiener JS, Shah SJ, Ho JE.   +36 more
europepmc   +6 more sources

Heart Failure with Mid-Range Ejection Fraction - State of the Art. [PDF]

Arq Bras Cardiol, 2019
In 2016, the European Society of Cardiology (ESC) recognized heart failure (HF) with ejection fraction between 40 and 49% as a new HF phenotype, HF with mid-range ejection fraction (HFmrEF), with the main purpose of encouraging studies on this new category.
Mesquita ET, Barbetta LMDS, Correia ETO.
europepmc   +7 more sources

Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. [PDF]

Eur Heart J, 2020
Abstract Secondary mitral regurgitation and secondary tricuspid regurgitation due to heart failure (HF) remain challenging in almost every aspect: increasing prevalence, poor prognosis, notoriously elusive in diagnosis, and complexity of therapeutic management.
Bartko PE, Hülsmann M, Hung J, Pavo N, Levine RA, Pibarot P, Vahanian A, Stone GW, Goliasch G.   +8 more
europepmc   +5 more sources

Heart Failure with Mid-range Ejection Fraction: Lessons from CHARM. [PDF]

Card Fail Rev, 2018
The newly defined category of heart failure (HF) with mid-range ejection fraction (HFmrEF; EF 40–49 %) is beginning to be characterised but little is known about the potential for treating it. Trials and observational studies suggest that standard therapy for HF with reduced ejection fraction (HFrEF; EF <40 %) may also offer some benefit to patients
Lund LH.
europepmc   +3 more sources

Heart rate in heart failure with mid-range ejection fraction. [PDF]

Anatol J Cardiol, 2019
Yılmaz MB.
europepmc   +4 more sources

Heart Failure with Mid-Range Ejection Fraction and How to Treat It. [PDF]

Card Fail Rev, 2018
Lopatin Y.
europepmc   +3 more sources